3D Cell Culture

Identifying tumor-specific cancer treatments using patient-derived tumor organoids

We speak with Dr. Benjamin Hopkins to learn how his team is pairing comprehensive genomics with drug screening of high-fidelity patient-derived organoids to help identify effective therapeutic strategies for cancer patients. 

Sustained release growth factor delivery with FGF2 DISCs for reproducible 3D cultures

Generation of mesenchymal stromal cell precursors in a 3D hollow fiber placenta co-culture model

Patient-derived organoid (PDO) gastrointestinal biobank

Combining multimodal analysis with tumor-specific 3D cell culture models